Blood News and Research

RSS

VolitionRx's two-assay test can detect 85% of colorectal cancer, more than 50% of precancerous polyps

VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today releases new data showing that when combining two of its proprietary NuQ assays into one test, they can achieve 85% detection rates at 85% specificity for colorectal cancer. The data also shows that Volition’s two-assay test can detect more than 50% of precancerous polyps. These new findings come from its ongoing prospective study with CHU Dinant Godinne | UCL Namur Hospital in Belgium.

4 Dec 2013

Another government shutdown possible in coming months, say majority of Americans in poll

Nearly two-thirds (65%) of Americans say it’s likely there will be another government shutdown in the months ahead as Congress continues to debate deficit and budget issues, according to a new national public opinion poll commissioned by Research!America and the American Society of Hematology.

4 Dec 2013

Research: Omega-3 fatty acids in dietary supplements can cross blood brain barrier in Alzheimer's patients

New research from Karolinska Institutet in Sweden shows that omega-3 fatty acids in dietary supplements can cross the blood brain barrier in people with Alzheimer's disease, affecting known markers for both the disease itself and inflammation.

4 Dec 2013

Lucane Pharma, Medunik Canada to offer new therapeutic option for patients suffering from UCD

Medunik Canada, a pharmaceutical company specialized in orphan drugs and Lucane Pharma, a French niche pharmaceutical company, announced the conclusion of an exclusive collaboration agreement.

4 Dec 2013

People who rely on visual identification of medications may risk poor BP control

People who identify their blood pressure medications by shape, size and color instead of by name may risk poor blood pressure control and increase their risk of hospitalization, finds a recent study in the Journal of Health Communication: International Perspectives.

4 Dec 2013

Linagliptin as monotherapy or in combination with metformin reduces blood glucose levels in T2D patients

Boehringer Ingelheim and Eli Lilly and Company today announced new data from a Phase IV study evaluating linagliptin (5 mg) as monotherapy and in combination with metformin (1500 or 2000 mg) in treatment-naive adults with newly diagnosed (<12 months) uncontrolled Type 2 Diabetes.

4 Dec 2013

Scientific poster on EKF's Quo-Test and Quo-Lab POCT HbA1c analyzers to be presented at IDF 2013

EKF, announces the successful assessment of its Quo-Test and Quo-Lab point-of-care HbA1c analyzers within the College of Medicine, Swansea University.

From EKF Diagnostics 4 Dec 2013

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Novartis will present updates on its broad cancer portfolio with more than 240 abstracts at the upcoming American Society of Hematology (ASH) annual meeting and CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).

4 Dec 2013

Newly discovered receptor may help in early diagnosis and treatment for sepsis

Sepsis, or septicaemia, is a devastating disease that is difficult to diagnose early and for which treatment options are limited. The number of deaths from sepsis exceeds those from lung cancer, and from breast and bowel cancer combined.

4 Dec 2013

White House readies new health law push after website woes

President Barack Obama and the White House will launch a new three-week health law offensive to re-sell the law to Americans after woes with the federal online website to buy health coverage hurt public perception of the law. Obama himself plans on buying coverage on the federal exchange website.

4 Dec 2013

Cognitive behavioral therapy for PTSD affects underlying biology of the disorder

A new paper published in Biological Psychiatry suggests that cognitive behavioral therapy for posttraumatic stress disorder not only reduces symptoms but also affects the underlying biology of this disorder.

4 Dec 2013

Presence of ERG protein in biopsied prostate tissue increases likelihood of cancer development

Researchers from Weill Cornell Medical College have shown that the presence of a particular protein in biopsied prostate tissue substantially increases the likelihood that cancer will develop in that organ. The discovery will likely help physicians decide how closely to monitor men potentially at risk for the cancer -- among the most confusing and controversial dilemmas in health care.

4 Dec 2013

Young people who combine alcohol with energy drinks can end up drinking more

Young people who combine alcohol with caffeine-laden energy drinks can end up drinking more than they intended to, finds a new study in the Journal of Adolescent Health.

4 Dec 2013

A new approach for treating colorectal cancer

Scientists and surgeons at Princess Margaret Cancer Centre have discovered a promising new approach to treating colorectal cancer by disarming the gene that drives self-renewal in stem cells that are the root cause of disease, resistance to treatment and relapse.

4 Dec 2013

CTCs serve as clinical tool to determine patient’s response to chemotherapy

Scientists from Granada have demonstrated, for the first time, that detecting circulating tumour cells (CTCs) in blood and studying the presence of certain genetic markers in them is a technique that allows specialists to predict, with great precision, the response that advanced-cancer patients will have to chemotherapy, as well as the associated secondary effects they may suffer.

4 Dec 2013

Researchers found that blood vessels in face transplant recipients reorganize themselves

For the first time, researchers have found that the blood vessels in face transplant recipients reorganize themselves, leading to an understanding of the biologic changes that happen after full face transplantation.

4 Dec 2013

Blood and tissue sample donations can help advance cancer research

Tucked away in freezers chilled to minus 80 degrees Celsius are blood and tissue samples from Cedars-Sinai patients. The freezers that hold these samples also contain the hopes of investigators determined to uncover new treatments for cancer patients across the globe.

4 Dec 2013

Rensselaer professors team up to develop innovative biomanufacturing technology

Two chemical engineering professors at Rensselaer Polytechnic Institute are contributing to a collaboration among academia, industry, and the federal government to develop a method for rapidly manufacturing biologic drugs.

4 Dec 2013

New research suggests that Alzheimer's gene may begin to affect brains in childhood

People who carry a high-risk gene for Alzheimer's disease show changes in their brains beginning in childhood, decades before the illness appears, new research from the Centre for Addiction and Mental Health suggests.

3 Dec 2013

Gladstone scientist devise new molecular sensor that can detect MS at earliest stages

For some, the disease multiple sclerosis attacks its victims slowly and progressively over a period of many years. For others, it strikes without warning in fits and starts. But all patients share one thing in common: the disease had long been present in their nervous systems, hiding under the radar from even the most sophisticated detection methods. But now, scientists at the Gladstone Institutes have devised a new molecular sensor that can detect MS at its earliest stages-even before the onset of physical signs.

3 Dec 2013

Blood News and Research

VolitionRx's two-assay test can detect 85% of colorectal cancer, more than 50% of precancerous polyps

Another government shutdown possible in coming months, say majority of Americans in poll

Research: Omega-3 fatty acids in dietary supplements can cross blood brain barrier in Alzheimer's patients

Lucane Pharma, Medunik Canada to offer new therapeutic option for patients suffering from UCD

People who rely on visual identification of medications may risk poor BP control

Linagliptin as monotherapy or in combination with metformin reduces blood glucose levels in T2D patients

Scientific poster on EKF's Quo-Test and Quo-Lab POCT HbA1c analyzers to be presented at IDF 2013

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Newly discovered receptor may help in early diagnosis and treatment for sepsis

White House readies new health law push after website woes

Cognitive behavioral therapy for PTSD affects underlying biology of the disorder

Presence of ERG protein in biopsied prostate tissue increases likelihood of cancer development

Young people who combine alcohol with energy drinks can end up drinking more

A new approach for treating colorectal cancer

CTCs serve as clinical tool to determine patient’s response to chemotherapy

Researchers found that blood vessels in face transplant recipients reorganize themselves

Blood and tissue sample donations can help advance cancer research

Rensselaer professors team up to develop innovative biomanufacturing technology

New research suggests that Alzheimer's gene may begin to affect brains in childhood

Gladstone scientist devise new molecular sensor that can detect MS at earliest stages

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News